These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1948646)

  • 1. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late radiation induced laryngeal oedema in the treatment of vocal cord cancer: analysis using the linear quadratic model.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Indian J Cancer; 1993 Sep; 30(3):113-9. PubMed ID: 8300140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of bioeffect dose models in radiation-induced late effects in glottic cancers.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Int J Radiat Oncol Biol Phys; 1992; 23(2):281-4. PubMed ID: 1587747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications.
    Deore SM; Shrivastava SK; Supe SJ; Viswanathan PS; Dinshaw KA
    Strahlenther Onkol; 1993 Sep; 169(9):521-6. PubMed ID: 8211671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined external and interstitial radiotherapy of vocal cord carcinoma].
    Hammer J; Hochleitner F; Meindl J; Seewald DH; Track C; Kundrath E
    Strahlenther Onkol; 1991 May; 167(5):277-81. PubMed ID: 2038710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of late rectal and recto-sigmoid complications related to fraction size in irradiation treatment of carcinoma cervix stage III B.
    Deore SM; Shrivastava SK; Viswanathan PS; Dinshaw KA
    Strahlenther Onkol; 1991 Nov; 167(11):638-42. PubMed ID: 1962277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperfractionated radiotherapy of early vocal cord cancer--adverse radiogenic reactions].
    Herrmann T; Alheit HD; Jochem I; Lesche A; Tölle D; Flach M
    Radiobiol Radiother (Berl); 1987; 28(3):297-307. PubMed ID: 3310083
    [No Abstract]   [Full Text] [Related]  

  • 9. [Percutaneous and interstitial radiotherapy in the function-preserving treatment of laryngeal carcinoma].
    Hammer J; Hochleitner F; Meindl J; Kundrath E
    Wien Med Wochenschr; 1991; 141(5-6):115-7. PubMed ID: 1903900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early carcinoma of the vocal cords. Kilovoltage results; telecobalt 60 dosimetry. (A preliminary report).
    Feder BH; Schaeflein JW; Stein JJ
    Am J Roentgenol Radium Ther Nucl Med; 1970 Feb; 108(2):269-77. PubMed ID: 5412863
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation therapy in carcinoma of the false cord.
    Cavanaugh PJ; Ferguson GB; Hudson WR; Worde BT; Raben M; Connell HC
    Radiology; 1969 Oct; 93(4):901-4. PubMed ID: 5824249
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer of the glottis: prognostic factors in radiation therapy.
    Mantravadi RV; Liebner EJ; Haas RE; Skolnik EM; Applebaum EL
    Radiology; 1983 Oct; 149(1):311-4. PubMed ID: 6611940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy T1 glottic carcinoma.
    Zablow AI; Erba PS; Sanfillippo LJ
    N J Med; 1989 Nov; 86(11):879-82. PubMed ID: 2608210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the radiation therapy of cancer of the true vocal cords].
    Kholin VV; Strashinin AI; Libson IL; Vladimirova VA
    Vopr Onkol; 1979; 25(4):11-6. PubMed ID: 433211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric predictors of laryngeal edema.
    Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal radiation after hemilaryngectomy.
    Lee F; Perlmutter S; Ogura JH
    Laryngoscope; 1980 Sep; 90(9):1534-9. PubMed ID: 7401854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
    Maciejewski B; Taylor JM; Withers HR
    Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local control and site of failure in radically irradiated supraglottic laryngeal cancer.
    Ghossein NA; Bataini JP; Ennuyer A; Stacey P; Krishnaswamy V
    Radiology; 1974 Jul; 112(1):187-92. PubMed ID: 4832491
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiation therapy of stage III laryngeal cancer].
    Alferov VS; Ogol'tsova ES; Kondrat'eva AP
    Med Radiol (Mosk); 1989 Dec; 34(12):36-9. PubMed ID: 2601591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy of T1N0 neoplasms of the glottis. Analysis of the parameters that influence local control].
    Bolner A; Valentini A; Amichetti M; Busana L; Fellin G; Menegotti L; Nassivera E; Pani G; Romano M
    Radiol Med; 1995 Dec; 90(6):804-7. PubMed ID: 8685467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.